DRUG
DRUG
NASDAQ · Biotechnology

Bright Minds Biosciences Inc

$18.96
-2.59 (-12.02%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +42.1% upside
Low Target $16.82
Average Target $26.95
High Target $32.06
Current Price $18.96
Current
$18.96
Target
$26.95
$16.82 $26.95 avg $32.06
Scenario Analysis
Bear Case
$16.82
-11.3%
Low target
Base Case
$26.95
+42.1%
Avg target
Bull Case
$32.06
+69.1%
High target
Risk/Reward
6.1x
Highly favorable
Price in Context
52-Week High
$170.00
-88.8% from high
52-Week Low
$68.02
+-72.1% from low
Target vs 52W High
$26.95
-84.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -35.8%